Opportunity Information: Apply for RFA MD 20 007
The National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health (NIH), released a limited-competition funding opportunity to create and operate a national Research Centers in Minority Institutions (RCMI) Coordinating Center (CC). This award uses a U24 cooperative agreement mechanism (meaning NIH will have substantial involvement in the project), and it explicitly does not allow clinical trials. The purpose of the Coordinating Center is to serve as the central hub that connects all NIMHD-funded RCMI sites, strengthens cross-site coordination, and helps the network function more effectively as a national program focused on minority health and health disparities research capacity.
The opportunity is anchored in the broader goals of the RCMI Specialized Centers program. Those goals include building and expanding institutional research capacity in basic biomedical, behavioral, and clinical research; improving the success of investigators at all career stages in securing competitive external funding (especially NIH awards), with particular attention to conditions that disproportionately affect minority and other health disparity populations; creating environments that support career growth, with a strong emphasis on early-career investigator development; raising the overall quality of scientific inquiry while advancing research directly relevant to minority health and health disparities; and establishing durable, mutually beneficial relationships with community-based organizations that partner with RCMI centers. In practice, the Coordinating Center is intended to help RCMI sites work as a connected national enterprise rather than as isolated centers, making it easier to share approaches, coordinate activities, and collectively advance the program mission.
The Coordinating Center is expected to work closely with key personnel at each RCMI site as well as NIMHD staff. Its role is largely facilitative and service-oriented: promoting and enabling communication across sites, encouraging collaboration, and organizing network-level activities that help centers meet RCMI program objectives. The CC is also expected to be responsive to requests and needs that come from multiple stakeholders, including RCMI site leadership, NIMHD and NIH, the broader scientific community, and the general public. This implies a strong emphasis on coordination infrastructure, dissemination, and network support functions rather than conducting independent hypothesis-driven clinical trials.
Eligibility is intentionally restricted. Applications are limited to institutions that are already funded through the RCMI program under specific prior funding announcements (RFA-MD-17-003, RFA-MD-17-006, or RFA-MD-18-012), reflecting the "limited competition" nature of the FOA. The listing of other eligible applicant types includes institutions and organizations commonly associated with serving underrepresented populations and supporting community-engaged work, such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and certain tribal governments and tribal organizations. However, the FOA also clearly bars non-U.S. entities and foreign components: non-domestic (non-U.S.) organizations and institutions cannot apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
From an administrative standpoint, this is a discretionary health-related federal assistance opportunity under CFDA 93.307, offered by NIH/NIMHD. The funding instrument is a cooperative agreement, which typically means the awardee and NIH program staff will collaborate on planning, priorities, and implementation for the national coordinating functions. The original application closing date was May 5, 2020, and the FOA is identified as RFA-MD-20-007. The public summary does not specify an award ceiling or the number of expected awards, but it frames the effort as establishing a single national coordinating center to support the full RCMI network.Apply for RFA MD 20 007
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.307.
- This funding opportunity was created on 2020-02-25.
- Applicants must submit their applications by 2020-05-05. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIMHD/NIH RCMI Coordinating Center (U24) - RFA-MD-20-007
What is this funding opportunity?
This is a limited-competition NIH/NIMHD funding opportunity to create and operate a national Research Centers in Minority Institutions (RCMI) Coordinating Center (CC). It is intended to function as a central hub that connects all NIMHD-funded RCMI sites and strengthens cross-site coordination so the RCMI network operates more effectively as a national program.
Which agency is offering the award?
The award is offered by the National Institute on Minority Health and Health Disparities (NIMHD), which is part of the National Institutes of Health (NIH).
What is the program mechanism and what does it imply?
The award uses a U24 cooperative agreement mechanism. A cooperative agreement indicates NIH will have substantial involvement in the project, meaning the awardee and NIH staff are expected to collaborate on planning, priorities, and implementation of the national coordinating functions.
Are clinical trials allowed under this opportunity?
No. The opportunity explicitly does not allow clinical trials.
What is the main purpose of the RCMI Coordinating Center?
The Coordinating Center is designed to serve as the central hub for the NIMHD-funded RCMI network. Its role is to connect sites, improve cross-site communication and collaboration, and support the network in functioning as a coordinated national enterprise rather than isolated centers.
How does the Coordinating Center relate to the broader goals of the RCMI Specialized Centers program?
The Coordinating Center supports the broader RCMI goals by strengthening network-wide infrastructure and coordination that help centers: build and expand institutional research capacity; improve investigator success in securing competitive external funding (especially NIH awards); support career growth with emphasis on early-career investigator development; raise the quality of scientific inquiry while advancing research relevant to minority health and health disparities; and foster durable community-based partnerships.
What kinds of activities is the Coordinating Center expected to carry out?
Based on the description provided, the Coordinating Center is expected to be facilitative and service-oriented, including: promoting and enabling communication across RCMI sites; encouraging collaboration; organizing network-level activities; and providing coordination infrastructure and dissemination to help centers meet RCMI program objectives.
Who will the Coordinating Center work with?
The Coordinating Center is expected to work closely with key personnel at each RCMI site and with NIMHD staff. It is also expected to be responsive to requests and needs from multiple stakeholders, including RCMI site leadership, NIMHD/NIH, the broader scientific community, and the general public.
Is this opportunity focused on running independent research projects?
The description emphasizes coordination, dissemination, and network support functions. It is presented as a hub that strengthens cross-site operations and collective progress toward program objectives, rather than a mechanism for conducting independent hypothesis-driven clinical trials.
Is the competition limited? Who can apply?
Yes. Eligibility is intentionally restricted. Applications are limited to institutions that are already funded through the RCMI program under the specified prior funding announcements: RFA-MD-17-003, RFA-MD-17-006, or RFA-MD-18-012.
Are there other types of organizations mentioned as eligible applicants?
The listing of eligible applicant types includes organizations commonly associated with serving underrepresented populations and supporting community-engaged work, including: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISI); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; regional organizations; U.S. territories or possessions; and certain tribal governments and tribal organizations.
Are non-U.S. organizations allowed to apply?
No. Non-domestic (non-U.S.) organizations and institutions cannot apply.
Are foreign components allowed as part of a U.S. organization?
No. The opportunity bars foreign components (as defined by NIH policy) and also states that non-domestic components of U.S. organizations are not eligible.
What is the CFDA number associated with this assistance opportunity?
The opportunity is described as a discretionary health-related federal assistance program under CFDA 93.307.
What is the FOA identifier?
The funding opportunity announcement (FOA) identifier is RFA-MD-20-007.
What was the application closing date listed in the summary?
The original application closing date was May 5, 2020.
How many awards are expected and is there an award ceiling?
The public summary provided does not specify an award ceiling or the number of expected awards. However, it frames the effort as establishing a single national Coordinating Center to support the full RCMI network.
What makes this award different from a typical grant?
Two features are highlighted: (1) it is a U24 cooperative agreement, which involves substantial NIH involvement; and (2) it is designed to provide national coordinating functions for the RCMI network, emphasizing facilitation, communication, collaboration support, and dissemination rather than clinical trials.
Browse more opportunities from the same category: Health
Next opportunity: Office of Postsecondary Education: Higher Education Emergency Relief Fund – IHEs 84.425E
Previous opportunity: Childhood Asthma in Urban Settings -Clinical Research Centers (U01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MD 20 007
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MD 20 007) also looked into and applied for these:
| Funding Opportunity |
|---|
| Alzheimers Disease Sequencing Project Functional Genomics Consortium (U01 Clinical Trial Not Allowed) Apply for RFA AG 21 006 Funding Number: RFA AG 21 006 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Multidisciplinary Studies to Improve Understanding of Influenza Transmission (U19 Clinical Trial Optional) Apply for RFA AI 20 008 Funding Number: RFA AI 20 008 Agency: National Institutes of Health Category: Health Funding Amount: $6,000,000 |
| Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed) Apply for RFA AI 20 003 Funding Number: RFA AI 20 003 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed) Apply for PAR 20 120 Funding Number: PAR 20 120 Agency: National Institutes of Health Category: Health Funding Amount: $3,000,000 |
| Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R01 Clinical Trial Optional) Apply for RFA AT 21 001 Funding Number: RFA AT 21 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R21 Clinical Trial Optional) Apply for RFA AT 21 002 Funding Number: RFA AT 21 002 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) Apply for PAR 20 123 Funding Number: PAR 20 123 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed) Apply for RFA AR 21 003 Funding Number: RFA AR 21 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed) Apply for RFA AI 20 016 Funding Number: RFA AI 20 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) Apply for PAR 20 127 Funding Number: PAR 20 127 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) Apply for PAS 20 121 Funding Number: PAS 20 121 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed) Apply for RFA AI 20 010 Funding Number: RFA AI 20 010 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 20 015 Funding Number: RFA AI 20 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (BMOR) (P30 - Clinical Trials Not Allowed) Apply for RFA AR 21 004 Funding Number: RFA AR 21 004 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Alzheimers Disease Research Centers (P30 Clinical Trial Not Allowed) Apply for RFA AG 21 019 Funding Number: RFA AG 21 019 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) Apply for RFA AI 20 028 Funding Number: RFA AI 20 028 Agency: National Institutes of Health Category: Health Funding Amount: $1,050,000 |
| Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R01 Clinical Trial Not Allowed) Apply for RFA DE 20 006 Funding Number: RFA DE 20 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Apply for PAR 20 139 Funding Number: PAR 20 139 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R21 Clinical Trial Not Allowed) Apply for RFA DE 20 007 Funding Number: RFA DE 20 007 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional) Apply for PAR 20 138 Funding Number: PAR 20 138 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MD 20 007", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
